Natus Medical Valuation Overview

BABY -- USA Stock  

USD 32.55  0.50  1.56%

Natus Medical Incorp secures last-minute Real Value of $42.15625 per share. The latest price of the firm is $32.55. At this time the firm appears to be under valued. Macroaxis forecasts value of Natus Medical Incorp from analyzing the firm fundamentals such as Current Valuation of 1.24B, Profit Margin of (4.71)% and Return On Equity of (5.68)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
 Time Horizon     30 Days    Login   to change
Natus Medical Incorporated is rated below average in price to sales category among related companies. It is rated fifth in beta category among related companies totaling about  0.40  of Beta per Price to Sales. The ratio of Price to Sales to Beta for Natus Medical Incorporated is roughly  2.48 

Current Market Valuation

Natus Medical Incorp Valuation Boundaries
Under Valued
July 20, 2018
Market Value
Real Value
Target Odds
Natus Medical is not too volatile asset. Calculation of real value of Natus Medical Incorp is based on 1 month time horizon. Increasing Natus Medical Incorp time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.